Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WSAVA publishes list of essential medicines for cats and dogs
"Many of our global colleagues lack access to even essential drugs" - Dr Paulo Steagall, co-chair of the TGG.

List hailed a ‘major milestone’ in efforts to support global drug availability

The World Small Animal Veterinary Association (WSAVA) has published the world's first list of essential medicines for cats and dogs in a bid to support global drug availability.


Compiled by the association’s Therapeutics Guidelines Group (TGG), the list aims to support companion animal vets in regions of the world who lack access to even the most fundamental medicines. It includes both core and complementary essential drugs listed alphabetically by category or organ system/speciality.

The extensively peer-reviewed list will be updated every three years. The WSAVA hopes this will boost the standard of care that veterinary surgeons can offer their patients worldwide and facilitate the regulatory oversight of medicines included on the list.

“Many of our global colleagues lack access to even essential drugs, such as opioid analgesics,” explained Dr Paulo Steagall, co-chair of the TGG. “This limits their ability to treat pain in their patients, leading to unnecessary suffering and compromising animal welfare.

“But it’s not just their patients that suffer. Our members and their colleagues experience deep frustration as they are unable to provide the standard of veterinary care they have been trained to deliver. For a profession already facing serious mental health problems, this is an unnecessary additional burden.”

In 2016, a survey of WSAVA’s 113 companion animal veterinary member associations revealed that 75 per cent faced obstacles accessing vital medicines. The WSAVA believes this is a longstanding issue that also affects colleagues working with production animals and human medics.

To help raise awareness of this issue, the WSAVA released two position statements in 2016 that were co-signed by numerous other international veterinary associations and trade bodies. It also created the TGG in 2018 to spearhead its work and safeguard the adoption of best-practice in adopting and using veterinary pharmaceuticals.

“As a global association, committed to advancing the health and welfare of companion animals worldwide, resolving the long-standing problem so many of our members face in accessing fundamental medicines is one of our most important priorities,” commented WSAVA president Dr Shane Ryan.

“We congratulate members of our TGG who have worked very hard to produce this comprehensive resource which is the next step in our campaign to secure access for all veterinarians to the drugs to they need to care for their patients.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.